GLOBOVAX Trademark

Trademark Overview


On Thursday, May 17, 2018, a trademark application was filed for GLOBOVAX with the United States Patent and Trademark Office. The USPTO has given the GLOBOVAX trademark a serial number of 87926196. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2019. This trademark is owned by OBI PHARMA, INC.. The GLOBOVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, vaccine for anti-cancer; chemical preparations for anti-cancer; vaccine for human use, namely, for the prevention and treatment of cancer, disorders of the immune system, and infectious diseases; pharmaceutical preparations, namely, anti-cancer preparations; medicines for human purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; medicinal agent for human use, namely, pharmaceutical preparations for the treatment of infectious diseases and for use in oncology, immune system related diseases and disorders; biological preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immu...
globovax

General Information


Serial Number87926196
Word MarkGLOBOVAX
Filing DateThursday, May 17, 2018
Status700 - REGISTERED
Status DateTuesday, March 26, 2019
Registration Number5708030
Registration DateTuesday, March 26, 2019
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements


Description of MarkThe mark consists of the word "GloboVax" in black with a pink stylized ribbon to the left and underneath.
Goods and ServicesPharmaceutical preparations, namely, vaccine for anti-cancer; chemical preparations for anti-cancer; vaccine for human use, namely, for the prevention and treatment of cancer, disorders of the immune system, and infectious diseases; pharmaceutical preparations, namely, anti-cancer preparations; medicines for human purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; medicinal agent for human use, namely, pharmaceutical preparations for the treatment of infectious diseases and for use in oncology, immune system related diseases and disorders; biological preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; pharmaceutical drugs, namely, drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations for the treatment of cancer
Indication of Colors claimedThe color(s) pink and black is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 25, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOBI PHARMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTaipei City 115011
TW

Party NameOBI PHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei City 115
TW

Party NameOBI PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 115
TW

Trademark Events


Event DateEvent Description
Wednesday, March 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 27, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 27, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 3, 2018ASSIGNED TO LIE
Tuesday, November 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 12, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, November 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, November 11, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 14, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 14, 2018NON-FINAL ACTION E-MAILED
Friday, September 14, 2018NON-FINAL ACTION WRITTEN
Monday, September 10, 2018ASSIGNED TO EXAMINER
Saturday, May 26, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 21, 2018NEW APPLICATION ENTERED